Skip to main content
. 2010 Mar 30;12(2):R57. doi: 10.1186/ar2969

Table 3.

Association with disease severity measures in early rheumatoid arthritis and in autoantibody-positive/antibody-negative disease

RA cohort Erosions Swollen joint count Health Assessment Questionnaire



Erosive, n (%) Per-allele OR (95% CI) P trend adj. a Mean (95% CI) Coefficient (95% CI) P trend adj.a Mean (95% CI) Coefficient (95% CI) P trend adj.a
HLA-DRB1 shared epitope 554 (21.5) n = 587 n = 587
 Negative 175 (22.9) 0.88 0.398 10.5 (9.5 to 11.5) -0.03 0.455 1.35 (1.24 to 1.47) -0.00 0.965
 One copy 278 (20.9) (0.65 to 1.19) 9.4 (8.7 to 10.1) (-1.04 to 0.47) 1.38 (1.29 to 1.46) (-0.09 to 0.09)
 Two copies 101 (20.8) 9.7 (8.4 to 11.0) 1.27 (1.14 to 1.41)
PTPN22 (rs2476601) 580 (20.7) n = 468 n = 468
 GG 423 (22.0) 0.75 0.189 9.5 (8.8 to 10.2) -0.02 0.593 1.32 (1.23 to 1.40) 0.06 0.133
 GA 147 (17.0) (0.48 to 1.16) 9.0 (7.8 to 10.1) (-1.31 to 0.75) 1.43 (1.30 to 1.56) (-0.03 to 0.21)
 AA 10 (20.0) 10.4 (1.9 to 18.9) 1.48 (0.35 to 2.61)
OLIG3/TNFAIP3 (rs6920220) 551 (20.3) n = 468 n = 468
 GG 302 (19.9) 1.03 0.853 9.4 (8.6 to 10.1) 0.04 0.291 1.36 (1.27 to 1.45) -0.01 0.880
 GA 217 (20.7) (0.73 to 1.46) 9.3 (8.3 to 10.2) (-0.39 to 1.31) 1.36 (1.24 to 1.48) (-0.11 to 0.09)
 AA 32 (21.9) 10.5 (7.7 to 13.3) 1.07 (0.76 to 1.37)
STAT4 (rs7574865) 476 (20.4) n = 468 n = 468
 GG 271 (22.1) 0.82 0.291 9.5 (8.7 to 10.2) 0.01 0.873 1.38 (1.28 to 1.47) -0.06 0.193
 GT/ 170 (18.2) (0.57 to 1.19) 9.3 (8.2 to 10.3) (-0.82 to 0.97) 1.35 (1.23 to 1.46) (-0.17 to 0.04)
 TT 35 (17.1) 9.5 (7.0 to 12.0) 1.12 (0.85 to 1.39)
TRAF1/C5 (rs10760130) 474 (20.3) n = 468 n = 468
 AA 140 (16.4) 1.18 (0.86 to 1.61) 0.311 9.7 (8.6 to 10.8) -0.03 0.502 1.25 (1.11 to 1.38) 0.09 0.031
 GA 225 (22.7) 9.1 (8.3 to 9.9) (-1.07 to 0.52) 1.34 (1.24 to 1.43) (0.01 to 0.19)
 GG 109 (20.2) 9.6 (8.4 to 10.8) 1.50 (1.35 to 1.65)

CI, confidence interval; OR, odds ratio; RA, rheumatoid arthritis. aAdjusted for symptom duration (all cases having a symptom duration <24 months).